Vagueness and murkiness with open-ended time frame......just more uncertainty piled on top of existing mounds of uncertainty. Would love to know who the cryptic and secret partner is as a shareholder.
Wash, rinse and repeat as the years roll along with massive dilution with the share price in triple zeros.
Respectfully, "days and weeks" just turned into months, so is there any chance of being able to walk into an American store and buy an ActiPatch based on the 4 FDA Clearances obtained or is it an all or nothing proposition based on the success of the 4th (by my count) re-submission for General Clearance?
BIEL is doing nothing with what they have, so why will they do anything with what they haven't got?
The product launch will be a very important introduction to the American market. First impressions can only happen once and it better be perfect. As long as the partner covers everything from A to Z in their launch, a everything will go well.
News 
Market Data 
Discover 
